A new study, in collaboration with the Wellcome Trust Sanger Institute and the University of Dundee, suggests the widespread use of earlier antibiotics such as penicillin rather than of methicillin itself allowed Methicillin resistant Staphylococcus aureus (MRSA) to emerge.
The findings, published in the open access journal Genome Biology, found that S. aureus acquired the gene that confers methicillin resistance (mecA) as early as the mid-1940s, fourteen years before the first use of methicillin.
Professor Matthew Holden, molecular microbiologist at the University of St Andrews, the corresponding author said:
“Our study provides important lessons for future efforts to combat antibiotic resistance. It shows that new drugs which are introduced to circumvent known resistance mechanisms, as methicillin was in 1959, can be rendered ineffective by unrecognized, pre-existing adaptations in the bacterial population. These adaptations happen because, in response to exposure to earlier antibiotics, resistant bacterial strains are selected instead of non-resistant ones as bacteria evolve.”
The mecA gene confers resistance by producing a protein called PBP2a, which decreases the binding efficiency of antibiotics used against S. aureus to the bacterial cell wall. The introduction of penicillin in the 1940s led to the selection of S. aureus strains that carried the methicillin resistance gene.
Dr Catriona Harkins, clinical lecturer in dermatology at the University of Dundee, the first author of the study said:
“Within a year of methicillin being first introduced to circumvent penicillin resistance, strains of S. aureus were found that were already resistant to methicillin. In the years that followed resistance spread rapidly in and outside of the UK. Five decades on from the appearance of the first MRSA, multiple MRSA lineages have emerged which have acquired different variants of the resistance gene.”
To uncover the origins of the very first MRSA and to trace its evolutionary history, the researchers sequenced the genomes of a unique collection of 209 historic S. aureus isolates. The oldest of these isolates were identified over 50 years ago by the S. aureus reference laboratory of Public Health England and have been stored ever since in their original freeze-dried state. The researchers also found genes in these isolates that confer resistance to numerous other antibiotics, as well as genes associated with decreased susceptibility to disinfectants.
Professor Holden said:
“S. aureus has proven to be particularly adept at developing resistance in the face of new antibiotic challenges, rendering many antibiotics ineffective. This remains one of the many challenges in tackling the growing problem of antimicrobial resistance. In order to ensure that future antibiotics retain their effectiveness for as long as possible, it is essential that effective surveillance mechanisms are combined with the use of genome sequencing to scan for the emergence and spread of resistance.”
Professor Holden is available for interview via the Communications Office – contacts below.
St Andrews has an in-house ISDN line for radio and a Globelynx camera for TV interviews. To arrange an interview please contact the Communications Office in the first instance.
Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Harkins et al Genome Biology 2017 DOI: 10.1186/s13059-017-1252-9
The full article is available at the journal website: https://genomebiology.biomedcentral.com/articles/10.1186/s13059-017-1252-9
Genome Biology publishes outstanding research in all areas of biology and biomedicine studied from a genomic and post-genomic perspective.
The Wellcome Trust Sanger Institute is one of the world’s leading genome centres. Through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower medical science globally. Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease. http://www.sanger.ac.uk
Issued by the University of St Andrews Communications Office. Contact Christine Tudhope on 01334 467 320 / 07526 624 243 or email@example.com.